Further characterization of interleukin-2 production by lymphocytes of patients with systemic lupus erythematosus
- PMID: 2972835
Further characterization of interleukin-2 production by lymphocytes of patients with systemic lupus erythematosus
Abstract
To further characterize the mechanisms responsible for defective interleukin-2 (IL-2) production in patients with systemic lupus erythematosus (SLE), we studied the effect of irradiation on the capacity of lymphocytes to produce this lymphokine when stimulated with phytohemagglutinin (PHA), or with a combination of PHA and a phorbol myristic acid ester (PMA). Irradiation increased PHA induced IL-2 production in patients with SLE and normal controls, and reached normal levels in 10 of 16 patients with SLE. This effect was due to inactivation of CD8+ suppressor cells. When PMA was used as a costimulant, maximal enhancement of IL-2 production was observed in both groups, but values in SLE remained significantly lower than in normals. These differences were not overcome by irradiation, raising the possibility that SLE suppressor cells act upon a site proximal to protein kinase C. Our studies have confirmed that active endogenous suppression may be responsible for most of the defective PHA induced IL-2 production in SLE and that this suppression is radiosensitive.
Similar articles
-
Phorbol myristate acetate (PMA) reverses inhibition of interleukin-2 production by T lymphocytes of patients with systemic lupus erythematosus.Med Interne. 1988 Jan-Mar;26(1):67-73. Med Interne. 1988. PMID: 3261032
-
Characterization of T lymphocyte subpopulations responsible for deficient interleukin 2 activity in patients with systemic lupus erythematosus.J Immunol. 1985 Jan;134(1):187-95. J Immunol. 1985. PMID: 3917275
-
Defective production of interleukin 1 and interleukin 2 in patients with systemic lupus erythematosus (SLE).J Immunol. 1983 Jun;130(6):2651-5. J Immunol. 1983. PMID: 6222112
-
[Effect of estrogen on the blast transformation of lymphocytes and interleukin-2 production in lupus erythematosus].Orv Hetil. 1992 May 10;133(19):1167-71. Orv Hetil. 1992. PMID: 1584598 Review. Hungarian.
-
[Cytokine production in patients with systemic lupus erythematosus].Orv Hetil. 1991 Sep 8;132(36):1971-4. Orv Hetil. 1991. PMID: 1923468 Review. Hungarian.
Cited by
-
Immune abnormalities induced by human endogenous retroviral peptides: with reference to the pathogenesis of systemic lupus erythematosus.J Clin Immunol. 2003 Sep;23(5):371-6. doi: 10.1023/a:1025369500466. J Clin Immunol. 2003. PMID: 14601645
-
The putative role of cytokines in the induction of primary anti-phospholipid syndrome in mice.Clin Exp Immunol. 1992 Nov;90(2):266-70. doi: 10.1111/j.1365-2249.1992.tb07940.x. Clin Exp Immunol. 1992. PMID: 1424285 Free PMC article.
-
Patient-Reported Outcomes in a Nationally Representative Sample of Older Internet Users: Cross-sectional Survey.JMIR Aging. 2021 Nov 24;4(4):e16006. doi: 10.2196/16006. JMIR Aging. 2021. PMID: 34822340 Free PMC article.
-
Longitudinal study on the production of and cellular response to interleukin-2 in patients with systemic lupus erythematosus.Rheumatol Int. 1995;15(2):57-63. doi: 10.1007/BF00262709. Rheumatol Int. 1995. PMID: 7481481
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Medical
Research Materials